Shuang Gong - Biostar Pharmaceuticals Secretary of Board
Executive
Ms. Shuang Gong is Secretary of Board of Biostar Pharmaceuticals Inc., since April 1, 2008. She was corporate secretary of Aoxing Pharmaceutical since 2006. She is also Administration Manager of Aoxing Pharmaceutical. From 1998 to 2000, She served as Assets Operation Manager of West Securities and Assistant Economist at West Securities she currently serves as Assistant Office Director of Aoxing Pharmaceutical since 2008.
Age | 56 |
Tenure | 17 years |
Phone | 86 29 3368 6638 |
Web | https://biostarpharmaceuticals.com |
Biostar Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0266 %, meaning that it created $0.0266 on every $100 dollars invested by stockholders. Biostar Pharmaceuticals' management efficiency ratios could be used to measure how well Biostar Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Elizabeth Geary | Ironwood Pharmaceuticals | N/A | |
Adam Mostafa | Cumberland Pharmaceuticals | 44 | |
Jean Marstiller | Cumberland Pharmaceuticals | 75 | |
John Hamm | Cumberland Pharmaceuticals | 68 | |
Jon Knight | Kamada | 59 | |
Hanni Neheman | Kamada | 55 | |
Tammi Gaskins | Ironwood Pharmaceuticals | N/A | |
Amir London | Kamada | 56 | |
Chris Bitterman | Cumberland Pharmaceuticals | 60 | |
Greg Martini | Ironwood Pharmaceuticals | 36 | |
Steve Laninga | Lifecore Biomedical | N/A | |
Darren Hieber | Lifecore Biomedical | N/A | |
Gene Esq | Shuttle Pharmaceuticals | N/A | |
Todd Anthony | Cumberland Pharmaceuticals | 64 | |
Matt Augustson | Lifecore Biomedical | N/A | |
Erin Gull | Cumberland Pharmaceuticals | N/A | |
Liron Reshef | Kamada | 54 | |
Jana Noeldeke | Ironwood Pharmaceuticals | N/A | |
Mike Nanfito | Ironwood Pharmaceuticals | N/A | |
Chaime Orlev | Kamada | 55 | |
Marcel Moulaison | Ironwood Pharmaceuticals | N/A |
Management Performance
Return On Equity | 0.0266 | ||||
Return On Asset | 0.0425 |
Biostar Pharmaceuticals Leadership Team
Elected by the shareholders, the Biostar Pharmaceuticals' board of directors comprises two types of representatives: Biostar Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biostar. The board's role is to monitor Biostar Pharmaceuticals' management team and ensure that shareholders' interests are well served. Biostar Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biostar Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Zhenghong Wang, Chief Officer | ||
Pr Zheng, Chief Scientist | ||
Ronghua Wang, Chairman, CEO and President Chairman of Aoxing Pharmaceutical Inc, CEO of Aoxing Pharmaceutical Inc and President of Aoxing Pharmaceutical Inc | ||
Xiaojuan Zhai, Chief Officer | ||
Shuang Gong, Secretary of Board |
Biostar Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Biostar Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0266 | ||||
Return On Asset | 0.0425 | ||||
Profit Margin | 2.94 % | ||||
Operating Margin | 8.76 % | ||||
Current Valuation | 316.46 K | ||||
Shares Outstanding | 2.64 M | ||||
Number Of Shares Shorted | 170.44 K | ||||
Price To Book | 0.01 X | ||||
Price To Sales | 0.0001 X | ||||
Revenue | 317.79 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Transaction History View history of all your transactions and understand their impact on performance |